Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.53 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.53 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.48 |
| ▸ | ZDHHC20 | Q5W0Z9 | 2/20 | 0.47 |
| ▸ | ZDHHC2 | Q9UIJ5 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | LCK | P06239 | 1/20 | 0.47 |
| ▸ | PPARD | Q03181 | 1/20 | 0.47 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acrylic Acid SCHEMBL7717223 | 1.00 | GPR84 (0.53) | GPR84FFAR1FFAR4ZDHHC20ZDHHC2 | |
| Acrylic Acid SCHEMBL18263622 | 1.00 | GPR84 (0.53) | GPR84FFAR1FFAR4ZDHHC20ZDHHC2 | |
| Acrylic Acid SCHEMBL2784024 | 1.00 | GPR84 (0.53) | GPR84FFAR1FFAR4ZDHHC20ZDHHC2 | |
| Acrylic Acid SCHEMBL1204508 | 1.00 | GPR84 (0.53) | GPR84FFAR1FFAR4ZDHHC20ZDHHC2 | |
| Acrylic Acid SCHEMBL9644753 | 1.00 | GPR84 (0.53) | GPR84FFAR1FFAR4ZDHHC20ZDHHC2 | |
| Acrylic Acid SCHEMBL11869433 | 1.00 | GPR84 (0.53) | GPR84FFAR1FFAR4ZDHHC20ZDHHC2 | |
| Acrylic Acid SCHEMBL29993104 | 0.98 | GPR84 (0.50) | GPR84FFAR1FFAR4ZDHHC20ZDHHC2 | |
| Acrylic Acid SCHEMBL29789041 | 0.98 | GPR84 (0.50) | GPR84FFAR1FFAR4ZDHHC20ZDHHC2 | |
| Acrylic Acid SCHEMBL160398 | 0.98 | GPR84 (0.50) | GPR84FFAR1FFAR4ZDHHC20ZDHHC2 | |
| Acrylic Acid SCHEMBL30753763 | 0.98 | GPR84 (0.50) | GPR84FFAR1FFAR4ZDHHC20ZDHHC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10814042-B2 | Radiopaque polymers for medical devices | ENDOSHAPE, INC. (US) | 2020-10-27 | — | — | US | disclosed |
| EP-2953650-B1 | RADIOPAQUE POLYMERS FOR MEDICAL DEVICES | ENDOSHAPE INC (US) | 2020-09-30 | — | — | EP | disclosed |
| CN-109563406-B | Solid polymer composition | 凡泰姆股份公司 | 2020-08-04 | — | — | CN | disclosed |
| US-20200061252-A1 | RADIOPAQUE POLYMERS FOR MEDICAL DEVICES | EMBOLIZATION, INC. | 2020-02-27 | — | — | US | disclosed |
| US-10434223-B2 | Radiopaque polymers for medical devices | ENDOSHAPE, INC. (US) | 2019-10-08 | — | — | US | disclosed |
| CN-109563406-A | Solid polymerization compositions | 凡泰姆股份公司 | 2019-04-02 | — | — | CN | disclosed |
| CN-108853610-A | Radiopaque polymer for medical device | 恩多沙普公司 | 2018-11-23 | — | — | CN | disclosed |
| US-20180126045-A1 | RADIOPAQUE POLYMERS FOR MEDICAL DEVICES | EMBOLIZATION, INC. | 2018-05-10 | — | — | US | disclosed |
| US-9789231-B2 | Radiopaque polymers for medical devices | ENDOSHAPE, INC. (US) | 2017-10-17 | — | — | US | disclosed |
| US-20150374884-A1 | RADIOPAQUE POLYMERS FOR MEDICAL DEVICES | EMBOLIZATION, INC. | 2015-12-31 | — | — | US | disclosed |
| EP-2953650-A1 | RADIOPAQUE POLYMERS FOR MEDICAL DEVICES | Endoshape, Inc. (US) | 2015-12-16 | — | — | EP | disclosed |
| CN-105073143-A | Radiopaque polymers for medical devices | ENDOSHAPE INC | 2015-11-18 | — | — | CN | disclosed |
| WO-2014124225-A1 | RADIOPAQUE POLYMERS FOR MEDICAL DEVICES | ENDOSHAPE, INC. (US) | 2014-08-14 | — | — | WO | disclosed |
| EP-2459677-A1 | PIEZOCHROME MATERIAL, PIEZOCHROME COMPOSITE MATERIAL AND PIEZOCHROME SENSOR | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2012-06-06 | — | — | EP | disclosed |
| WO-2011012315-A1 | PIEZOCHROME MATERIAL, PIEZOCHROME COMPOSITE MATERIAL AND PIEZOCHROME SENSOR | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2011-02-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180126045-A1 | RADIOPAQUE POLYMERS FOR MEDICAL DEVICES | PARN, MMS19, RAD50 | GPR84 2313/4885FFAR1 1241/4885FFAR4 2877/4885 |
| US-10814042-B2 | Radiopaque polymers for medical devices | PARN, MMS19, RAD50 | GPR84 2313/4885FFAR1 1241/4885FFAR4 2877/4885 |
| US-20200061252-A1 | RADIOPAQUE POLYMERS FOR MEDICAL DEVICES | PARN, MMS19, RAD50 | GPR84 2313/4885FFAR1 1241/4885FFAR4 2877/4885 |
| US-10434223-B2 | Radiopaque polymers for medical devices | PARN, MMS19, RAD50 | GPR84 2313/4885FFAR1 1241/4885FFAR4 2877/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.